Eli Lilly (LLY) Net Cash Flow Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
-568.73% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-85.99% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
1,265.92% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-95.55% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
191.97% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
103.60% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
42.41% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-227.06% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-568.73% |
| Dec 31, 2025 |
-850.27% |
| Sep 30, 2025 |
7,933.50% |
| Jun 30, 2025 |
-99.14% |
| Mar 31, 2025 |
4.92% |
| Dec 31, 2024 |
6.13% |
| Sep 30, 2024 |
74.45% |
| Jun 30, 2024 |
195.63% |
| Mar 31, 2024 |
-122.21% |
| Dec 31, 2023 |
173.07% |
| Sep 30, 2023 |
-16,689.47% |
| Jun 30, 2023 |
-469.20% |
| Mar 31, 2023 |
204.39% |
| Dec 31, 2022 |
-268.21% |
| Sep 30, 2022 |
-100.34% |
| Jun 30, 2022 |
11.53% |
| Mar 31, 2022 |
-116.12% |
| Dec 31, 2021 |
266.89% |
| Sep 30, 2021 |
-54.56% |
| Jun 30, 2021 |
-65.84% |
| Mar 31, 2021 |
-12.71% |
| Dec 31, 2020 |
-118.60% |
| Sep 30, 2020 |
300.13% |
| Jun 30, 2020 |
169.87% |
| Mar 31, 2020 |
90.47% |
| Dec 31, 2019 |
195.14% |
| Sep 30, 2019 |
-128.13% |
| Jun 30, 2019 |
-94.06% |
| Mar 31, 2019 |
-66.64% |
| Dec 31, 2018 |
-129.78% |
| Sep 30, 2018 |
245.69% |
| Jun 30, 2018 |
726.55% |
| Mar 31, 2018 |
-83.18% |
| Dec 31, 2017 |
135.18% |
| Sep 30, 2017 |
133.72% |
| Jun 30, 2017 |
-51.88% |
| Mar 31, 2017 |
-52.51% |
| Dec 31, 2016 |
220.72% |
| Sep 30, 2016 |
540.43% |
| Jun 30, 2016 |
411.34% |
| Mar 31, 2016 |
-106.13% |
| Dec 31, 2015 |
-52.65% |
| Sep 30, 2015 |
83.37% |
| Jun 30, 2015 |
259.83% |
| Mar 31, 2015 |
-1,053.05% |
| Dec 31, 2014 |
247.44% |
| Sep 30, 2014 |
-170.22% |
| Jun 30, 2014 |
20.77% |
| Mar 31, 2014 |
1,390.91% |
| Dec 31, 2013 |
59.12% |
| Sep 30, 2013 |
-40.15% |
| Jun 30, 2013 |
-140.30% |
| Mar 31, 2013 |
100.24% |
| Dec 31, 2012 |
-127.39% |
| Sep 30, 2012 |
38.88% |
| Jun 30, 2012 |
187.08% |
| Mar 31, 2012 |
-540.42% |
| Dec 31, 2011 |
-611.40% |
| Sep 30, 2011 |
8.22% |
| Jun 30, 2011 |
-167.52% |
| Mar 31, 2011 |
17.63% |
| Dec 31, 2010 |
-82.07% |
| Sep 30, 2010 |
25.34% |
| Jun 30, 2010 |
826.10% |
| Mar 31, 2010 |
117.35% |
